Report Detail

Pharma & Healthcare Global Bulk Drug Market Insights and Forecast to 2026

  • RnM4117521
  • |
  • 06 August, 2020
  • |
  • Global
  • |
  • 152 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Bulk Drug market is segmented 5, and 2. Players, stakeholders, and other participants in the global Bulk Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast 5 and 2 for the period 2015-2026.

Segment 5, the Bulk Drug market is segmented into
Antibiotics
Sulpha Drugs
Vitamins,
Steroids
Analgesics
Others

Segment 2, the Bulk Drug market is segmented into
Hospitals
Clinics
Others

Regional and Country-level Analysis
The Bulk Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bulk Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, United States, Canada, Germany, France, UK, Italy, Russia, China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Brazil, Turkey, GCC Countries, Egypt, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast 5, and 2 segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bulk Drug Market Share Analysis
Bulk Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bulk Drug business, the date to enter into the Bulk Drug market, Bulk Drug product introduction, recent developments, etc.

The major vendors covered:
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group


1 Study Coverage

  • 1.1 Bulk Drug Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Bulk Drug Manufacturers Covered: Ranking by Revenue
  • 1.4 Market 5
    • 1.4.1 Global Bulk Drug Market Size Growth Rate 5
    • 1.4.2 Antibiotics
    • 1.4.3 Sulpha Drugs
    • 1.4.4 Vitamins,
    • 1.4.5 Steroids
    • 1.4.6 Analgesics
    • 1.4.7 Others
  • 1.5 Market 2
    • 1.5.1 Global Bulk Drug Market Size Growth Rate 2
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Bulk Drug Market Size, Estimates and Forecasts
    • 2.1.1 Global Bulk Drug Revenue 2015-2026
    • 2.1.2 Global Bulk Drug Sales 2015-2026
  • 2.2 Global Bulk Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Bulk Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Bulk Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Bulk Drug Competitor Landscape by Players

  • 3.1 Bulk Drug Sales by Manufacturers
    • 3.1.1 Bulk Drug Sales by Manufacturers (2015-2020)
    • 3.1.2 Bulk Drug Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Bulk Drug Revenue by Manufacturers
    • 3.2.1 Bulk Drug Revenue by Manufacturers (2015-2020)
    • 3.2.2 Bulk Drug Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Bulk Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Bulk Drug Revenue in 2019
    • 3.2.5 Global Bulk Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Bulk Drug Price by Manufacturers
  • 3.4 Bulk Drug Manufacturing Base Distribution, Product Types
    • 3.4.1 Bulk Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Bulk Drug Product Type
    • 3.4.3 Date of International Manufacturers Enter into Bulk Drug Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size 5 (2015-2026)

  • 4.1 Global Bulk Drug Market Size 5 (2015-2020)
    • 4.1.1 Global Bulk Drug Sales 5 (2015-2020)
    • 4.1.2 Global Bulk Drug Revenue 5 (2015-2020)
    • 4.1.3 Bulk Drug Average Selling Price (ASP) 5 (2015-2026)
  • 4.2 Global Bulk Drug Market Size Forecast 5 (2021-2026)
    • 4.2.1 Global Bulk Drug Sales Forecast 5 (2021-2026)
    • 4.2.2 Global Bulk Drug Revenue Forecast 5 (2021-2026)
    • 4.2.3 Bulk Drug Average Selling Price (ASP) Forecast 5 (2021-2026)
  • 4.3 Global Bulk Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size 2 (2015-2026)

  • 5.1 Global Bulk Drug Market Size 2 (2015-2020)
    • 5.1.1 Global Bulk Drug Sales 2 (2015-2020)
    • 5.1.2 Global Bulk Drug Revenue 2 (2015-2020)
    • 5.1.3 Bulk Drug Price 2 (2015-2020)
  • 5.2 Bulk Drug Market Size Forecast 2 (2021-2026)
    • 5.2.1 Global Bulk Drug Sales Forecast 2 (2021-2026)
    • 5.2.2 Global Bulk Drug Revenue Forecast 2 (2021-2026)
    • 5.2.3 Global Bulk Drug Price Forecast 2 (2021-2026)

6 North America

  • 6.1 North America Bulk Drug by Country
    • 6.1.1 North America Bulk Drug Sales by Country
    • 6.1.2 North America Bulk Drug Revenue by Country
    • 6.1.3 United States
    • 6.1.4 Canada
    • 6.1.5 Mexico
  • 6.2 North America Bulk Drug Market Facts & Figures 5
  • 6.3 North America Bulk Drug Market Facts & Figures 2

7 Europe

  • 7.1 Europe Bulk Drug by Country
    • 7.1.1 Europe Bulk Drug Sales by Country
    • 7.1.2 Europe Bulk Drug Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 UK
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Bulk Drug Market Facts & Figures 5
  • 7.3 Europe Bulk Drug Market Facts & Figures 2

8 Asia Pacific

  • 8.1 Asia Pacific Bulk Drug by Region
    • 8.1.1 Asia Pacific Bulk Drug Sales by Region
    • 8.1.2 Asia Pacific Bulk Drug Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Indonesia
    • 8.1.9 Thailand
    • 8.1.10 Malaysia
    • 8.1.11 Philippines
    • 8.1.12 Vietnam
  • 8.2 Asia Pacific Bulk Drug Market Facts & Figures 5
  • 8.3 Asia Pacific Bulk Drug Market Facts & Figures 2

9 Latin America

  • 9.1 Latin America Bulk Drug by Country
    • 9.1.1 Latin America Bulk Drug Sales by Country
    • 9.1.2 Latin America Bulk Drug Revenue by Country
    • 9.1.3 Brazil
  • 9.2 Central & South America Bulk Drug Market Facts & Figures 5
  • 9.3 Central & South America Bulk Drug Market Facts & Figures 2

10 Middle East and Africa

  • 10.1 Middle East and Africa Bulk Drug by Country
    • 10.1.1 Middle East and Africa Bulk Drug Sales by Country
    • 10.1.2 Middle East and Africa Bulk Drug Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 GCC Countries
    • 10.1.5 Egypt
    • 10.1.6 South Africa
  • 10.2 Middle East and Africa Bulk Drug Market Facts & Figures 5
  • 10.3 Middle East and Africa Bulk Drug Market Facts & Figures 2

11 Company Profiles

  • 11.1 Teva
    • 11.1.1 Teva Corporation Information
    • 11.1.2 Teva Description and Business Overview
    • 11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Teva Bulk Drug Products Offered
    • 11.1.5 Teva Related Developments
  • 11.2 Novartis
    • 11.2.1 Novartis Corporation Information
    • 11.2.2 Novartis Description and Business Overview
    • 11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis Bulk Drug Products Offered
    • 11.2.5 Novartis Related Developments
  • 11.3 Pfizer
    • 11.3.1 Pfizer Corporation Information
    • 11.3.2 Pfizer Description and Business Overview
    • 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Pfizer Bulk Drug Products Offered
    • 11.3.5 Pfizer Related Developments
  • 11.4 Johnson & Johnson
    • 11.4.1 Johnson & Johnson Corporation Information
    • 11.4.2 Johnson & Johnson Description and Business Overview
    • 11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Johnson & Johnson Bulk Drug Products Offered
    • 11.4.5 Johnson & Johnson Related Developments
  • 11.5 Mylan
    • 11.5.1 Mylan Corporation Information
    • 11.5.2 Mylan Description and Business Overview
    • 11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Mylan Bulk Drug Products Offered
    • 11.5.5 Mylan Related Developments
  • 11.6 North China Pharmaceutical Group
    • 11.6.1 North China Pharmaceutical Group Corporation Information
    • 11.6.2 North China Pharmaceutical Group Description and Business Overview
    • 11.6.3 North China Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 North China Pharmaceutical Group Bulk Drug Products Offered
    • 11.6.5 North China Pharmaceutical Group Related Developments
  • 11.7 Dr. Reddy’s Laboratories
    • 11.7.1 Dr. Reddy’s Laboratories Corporation Information
    • 11.7.2 Dr. Reddy’s Laboratories Description and Business Overview
    • 11.7.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Dr. Reddy’s Laboratories Bulk Drug Products Offered
    • 11.7.5 Dr. Reddy’s Laboratories Related Developments
  • 11.8 Roche
    • 11.8.1 Roche Corporation Information
    • 11.8.2 Roche Description and Business Overview
    • 11.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Roche Bulk Drug Products Offered
    • 11.8.5 Roche Related Developments
  • 11.9 Aurobindo pharma
    • 11.9.1 Aurobindo pharma Corporation Information
    • 11.9.2 Aurobindo pharma Description and Business Overview
    • 11.9.3 Aurobindo pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Aurobindo pharma Bulk Drug Products Offered
    • 11.9.5 Aurobindo pharma Related Developments
  • 11.10 Sun Pharmaceutical Industries
    • 11.10.1 Sun Pharmaceutical Industries Corporation Information
    • 11.10.2 Sun Pharmaceutical Industries Description and Business Overview
    • 11.10.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Sun Pharmaceutical Industries Bulk Drug Products Offered
    • 11.10.5 Sun Pharmaceutical Industries Related Developments
  • 11.1 Teva
    • 11.1.1 Teva Corporation Information
    • 11.1.2 Teva Description and Business Overview
    • 11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Teva Bulk Drug Products Offered
    • 11.1.5 Teva Related Developments
  • 11.12 Bayer
    • 11.12.1 Bayer Corporation Information
    • 11.12.2 Bayer Description and Business Overview
    • 11.12.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Bayer Products Offered
    • 11.12.5 Bayer Related Developments
  • 11.13 BASF
    • 11.13.1 BASF Corporation Information
    • 11.13.2 BASF Description and Business Overview
    • 11.13.3 BASF Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 BASF Products Offered
    • 11.13.5 BASF Related Developments
  • 11.14 DSM
    • 11.14.1 DSM Corporation Information
    • 11.14.2 DSM Description and Business Overview
    • 11.14.3 DSM Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 DSM Products Offered
    • 11.14.5 DSM Related Developments
  • 11.15 Zhejiang Medicine
    • 11.15.1 Zhejiang Medicine Corporation Information
    • 11.15.2 Zhejiang Medicine Description and Business Overview
    • 11.15.3 Zhejiang Medicine Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Zhejiang Medicine Products Offered
    • 11.15.5 Zhejiang Medicine Related Developments
  • 11.16 Biocon
    • 11.16.1 Biocon Corporation Information
    • 11.16.2 Biocon Description and Business Overview
    • 11.16.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Biocon Products Offered
    • 11.16.5 Biocon Related Developments
  • 11.17 Johnson Matthey
    • 11.17.1 Johnson Matthey Corporation Information
    • 11.17.2 Johnson Matthey Description and Business Overview
    • 11.17.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Johnson Matthey Products Offered
    • 11.17.5 Johnson Matthey Related Developments
  • 11.18 Hisun Pharmacy
    • 11.18.1 Hisun Pharmacy Corporation Information
    • 11.18.2 Hisun Pharmacy Description and Business Overview
    • 11.18.3 Hisun Pharmacy Sales, Revenue and Gross Margin (2015-2020)
    • 11.18.4 Hisun Pharmacy Products Offered
    • 11.18.5 Hisun Pharmacy Related Developments
  • 11.19 Cambrex
    • 11.19.1 Cambrex Corporation Information
    • 11.19.2 Cambrex Description and Business Overview
    • 11.19.3 Cambrex Sales, Revenue and Gross Margin (2015-2020)
    • 11.19.4 Cambrex Products Offered
    • 11.19.5 Cambrex Related Developments
  • 11.20 Shandong Xinhua Pharmaceutical
    • 11.20.1 Shandong Xinhua Pharmaceutical Corporation Information
    • 11.20.2 Shandong Xinhua Pharmaceutical Description and Business Overview
    • 11.20.3 Shandong Xinhua Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.20.4 Shandong Xinhua Pharmaceutical Products Offered
    • 11.20.5 Shandong Xinhua Pharmaceutical Related Developments
  • 11.21 Lonza group
    • 11.21.1 Lonza group Corporation Information
    • 11.21.2 Lonza group Description and Business Overview
    • 11.21.3 Lonza group Sales, Revenue and Gross Margin (2015-2020)
    • 11.21.4 Lonza group Products Offered
    • 11.21.5 Lonza group Related Developments
  • 11.22 Huahai Pharmaceutical
    • 11.22.1 Huahai Pharmaceutical Corporation Information
    • 11.22.2 Huahai Pharmaceutical Description and Business Overview
    • 11.22.3 Huahai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.22.4 Huahai Pharmaceutical Products Offered
    • 11.22.5 Huahai Pharmaceutical Related Developments
  • 11.23 Haerbin Pharmaceutical Group
    • 11.23.1 Haerbin Pharmaceutical Group Corporation Information
    • 11.23.2 Haerbin Pharmaceutical Group Description and Business Overview
    • 11.23.3 Haerbin Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.23.4 Haerbin Pharmaceutical Group Products Offered
    • 11.23.5 Haerbin Pharmaceutical Group Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Bulk Drug Market Estimates and Projections by Region
    • 12.1.1 Global Bulk Drug Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Bulk Drug Revenue Forecast by Regions 2021-2026
  • 12.2 North America Bulk Drug Market Size Forecast (2021-2026)
    • 12.2.1 North America: Bulk Drug Sales Forecast (2021-2026)
    • 12.2.2 North America: Bulk Drug Revenue Forecast (2021-2026)
    • 12.2.3 North America: Bulk Drug Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Bulk Drug Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Bulk Drug Sales Forecast (2021-2026)
    • 12.3.2 Europe: Bulk Drug Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Bulk Drug Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Bulk Drug Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Bulk Drug Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Bulk Drug Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Bulk Drug Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Bulk Drug Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Bulk Drug Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Bulk Drug Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Bulk Drug Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Bulk Drug Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Bulk Drug Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Bulk Drug Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Bulk Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Bulk Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Bulk Drug Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Bulk Drug. Industry analysis & Market Report on Bulk Drug is a syndicated market report, published as Global Bulk Drug Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Bulk Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,069.30
    4,603.95
    6,138.60
    3,591.90
    5,387.85
    7,183.80
    608,712.00
    913,068.00
    1,217,424.00
    324,948.00
    487,422.00
    649,896.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report